View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 13, 2022

Namida Lab to start clinical trial of breast cancer screening test

The clinical study will assess the performance of Melody as a supplemental tool to current screening methods.

Namida Lab will conduct a clinical study to assess the performance of a tear-based breast cancer screening test, Melody, for women with dense breast tissue.

Melody is a simple, accurate, inexpensive and convenient screening test for breast cancer that uses proteins from tears.

It has been developed as a supplemental tool to existing screening recommendations.

According to the company, dense breast tissue is detected in roughly 50% of mammograms. While these images can help to measure the amount of glandular and connective tissue compared to fatty tissue, other clinically relevant findings, including tumours, can be obscured by dense breast tissue.

The clinical study will be conducted at The University of Texas MD Anderson Cancer Center. It will begin this month and continue for six months.

Approximately 100 women will be enrolled in the tear collection study, which will be fully funded by Namida Lab.

Namida Lab product development and innovation vice-president Anna Daily said: “This study will lead to incredible outcomes to implement Melody as a part of the current screening process for women with dense breast tissue, since the results of Melody are not limited by tissue type, and therefore a promising avenue in detecting breast abnormalities.”

The company stated that women who have previously been identified as having dense breast tissue and are booked to have a mammogram will be offered the chance to enrol in the study.

The subjects’ tear samples will be collected by placing a strip of filter paper in the lower eyelid for about five minutes. This strip will be sent to Namida Lab to be assessed for breast cancer markers.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network